Roberto A. Leon Ferre, MD, oncologist, Mayo Clinic, discusses the identification of patients with luminal androgen receptor (LAR) triple-negative breast cancer (TNBC) during the 2018 San Antonio Breast Cancer Symposium.
Roberto A. Leon Ferre, MD
Articles by Roberto A. Leon Ferre, MD
Latest Updated Articles
Identification of Patients With Luminal Androgen Receptor TNBCDecember 5th 2018